The Fastest Path to Commercial Insights
We help life sciences teams get smart – fast – on any disease market and answer critical commercial questions with fresh KOL-driven insights delivered in as little as four weeks.
Rare disease is our core strength – and where
we go deepest.
We built our expertise where evidence is fragmented, standards of care are shifting, and secondary research alone falls short – then extended that same rigor to oncology, niche subpopulations, and other complex markets.
See Our Disease Coverage →Rare Disease
Sparse evidence, evolving standards of care, small populations – we build the picture others can't.
Oncology
Shifting standards of care and competitive complexity demand current, focused insight.
Niche Subpopulations
Distinct opportunities within prevalent diseases that broad market-level research can overlook.
Meet tight deadlines without
sacrificing rigor
Pipeline planning doesn't pause for lengthy research timelines.
REACH helps pharmaceutical and biotech teams:
- Build foundational market understanding
- Define and refine target product profiles
- Get fast, custom answers to your most specific questions
- Develop a business case for an asset
- Triangulate key data and pressure-test internal assumptions
From kickoff to a delivered report, backed by fresh KOL fieldwork.
Two ways to get the insights you need
Whether you need to understand an unfamiliar market or answer focused questions in one you already know, REACH can tailor the scope, depth, and timeline.
Need to get smart on a market?
Get a cost-effective, forward-looking view of an unfamiliar market. Choose the depth you need – from a concise market primer to a comprehensive commercial assessment incorporating fresh physician insights, TPP testing, and optional payer research.
Access existing intelligence immediately or commission a new or refreshed assessment in as little as four weeks.
Explore MarketVue® →Already know your market?
Go straight to focused primary research addressing your proprietary business questions without paying for foundational landscape research you don't need. Qualitative interviews, quantitative surveys, TPP testing, and payer research can be completed in as little as three weeks.
Explore Rapid Insights →Every engagement is:
Primary research-driven
Fresh physician and payer insights—not secondary research alone.
Senior-led, every time
Experienced researchers remain involved from study design through final implications.
Built around your decision
Scope, respondents, and outputs tailored to the commercial question.
From business questions to actionable insights
Request
Tell us the disease or business question you're facing
Questions
We finalize scope, respondents, and research approach
Research
Conduct fresh interviews and/or surveys
Deliver
Translate findings into insights and implications you can act on
Commercial teams making critical asset and market decisions
"I need something beyond what I can do for myself with Google and without paying an extraordinary amount of money… REACH operates with the best aspects of primary research but then benefits like speed of syndicated reports."
"MarketVue® is very valuable to get fast reports and at the right level of detail. We were originally supposed to develop disease strategies but then we had a reorganization and resources were constrained. REACH is a great help to us."
"With MarketVue® reports, you can get 80–90% of output for 10% of the cost of custom consulting — this is great, especially for small clients like us whose budgets are tight, and we don't have a ton of FTEs."
"MarketVue® is really high quality in general and comparable to much more expensive reports where you get a 100-page report — in terms of value for the amount we use it, it is comparable to much, much more expensive research."
"REACH reports give you the ability to tailor the research a little bit more. I work in rare disease where syndicated reports just don't exist and if they do, they're not built out. I value the REACH team's ability and willingness to answer follow up questions, dive in around specific topics, and think critically with us around the implications of the findings."
"What pushed me over the edge was that they have a nice way of presenting the findings in the end. Their output was very clean and useful for putting into our slides. REACH can be a thought partner — they take what we're saying and riff off of us, then come up with additional ideas."
Get the insights you need to move forward
Tell us the market or commercial decision you're facing. We'll recommend the most focused path to the answers you need.